Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)
Clinical trial NCT07654829 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07654829
- Sponsor
- KalVista Pharmaceuticals, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-11-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.